Slide 1 IPERTENSIONE ARTERIOSA E NEFROPATIA 1) Ruolo nellaumento del rischio cardio vascolare 2) Parametri di valutazione 3) Correlazioni con il profilo metabolico Dott.ssa…

Slide 1 Gabriele Riccardi Chair of Endocrinology and Metabolic Diseases, Federico II University, Naples, Italy Diabete e danno vascolare: il nesso fisiopatologico comune…

Slide 1 CARD-1071581-0000-CZR-SS-02/2015 Data deposito AIFA 13 ottobre 2009 The L osartan I ntervention F or E ndpoint Reduction in Hypertension Study Studio internazionale,…

1.Orientation to Library Resources for Internal Medicine July 29th, 2010 Robin Featherstone Clinical Medicine Librarian, UWO [email_address] Erin Boyce Clinical Librarian,…

1.Jafar Al-Said, M.B. CHb. MD. FASN. FACP Nephrology and Internal Medicine Consultant Bahrain Specialist Hospital2. Adjusted prevalent rates of ESRD & annual percent…

1.New Approaches to the Treatment of Hyperphosphataemia Dr. Alastair J. Hutchison MBChB, FRCP, MD Manchester Institute of Nephrology & Transplantation, UK2. Risk factors…

1.Dr. Eddy Susatyo, SpPD FinaSIM RSU dr. Sutrasno Rembang Gangguan sistem urologi fokus gagal ginjal 2. STRUCTURE OF THE KIDNEYS 3. Chronic Kidney Disease ? 4. Definition…

Dia 1 Kijk naar de nieren en leer over het hart Bart De Moor namens Hilde Keuleers, Koen Stas en Johan vanwalleghem Virga Jesseziekenhuis Dia 2 End- Stage Progression Initiation…

1. Jose L. Rodriguez , MD Tuesday 6 June 2014 Oshakati Hospital.Namibia. 2.  At the conclusion of this presentation, the students physician should be able to: oKnown anatomy…

1. Dosing Dialysis: Is More Better ? “ Dialysis in the 21st Century”Chicago, Illinois September 19, 2004 Robert S. Lockridge Jr. MD Lynchburg Nephrology Physicians 2.…